Here is the percentage of Ghanaians who rely on herbal medicine
Up to 70–80 percent of Ghanaians rely on herbal medicine in their healthcare, according to Dr Sandra Ashong,…
Minoxidil, AI and the Next Hair-Loss Breakthrough
Hair loss is no longer a niche concern. Dermatologists are seeing more patients than ever, especially women in…
Ozempic, Wegovy list prices to be slashed by up to 50%
Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50%…
Senate Leaders Warn Hegseth About Procuring Generic Drugs Overseas — ProPublica
Senate leaders are urging the Department of Defense to prioritize the purchase of generic drugs manufactured in the…
New GLP-1 pill helps patients lose up to 8% of body weight, trial shows | Weight-loss drugs
A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical…
Scientists discover tribal medicine for dogs in N. Ecija as distinct plant species
A plant long used by the indigenous Bugkalot folk of Nueva Ecija to treat ailing dogs has now…
Medication shortage hits UK as statins and aspirin ‘disappear from shelves’
A pharmacist has warned people the UK has been hit with a medication shortage. Even popular medicines like…
NAFDAC alerts Nigerians to falsified Dostinex tablets in circulation
The National Agency for Food and Drug Administration and Control has warned healthcare providers, patients, and the public…
Breakthrough method gives ‘snapshot’ of a plant’s metabolic effects
Scientists developed a new way to help understand what happens in the body when people consume a plant…
GLP-1 Medications for Weight Loss: How to Get Started | News
Any licensed health care provider—including primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists,…
Has Australia’s social media ban worked? The eSafety Commissioner is monitoring kids’ Ritalin use to find out
February 26, 2026 — 12:01am Save You have reached your maximum number of saved items. Remove items from…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…